Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Substitute for HB 1989 advances to clarify medical cannabis labeling and delivery, 6–0
Summary
A House subcommittee unanimously reported a substitute for HB 1989 that updates medical cannabis labeling (milligrams for edibles/topicals, THC/CBD percentages for inhalables) and clarifies delivery rules for qualified patients, prompting discussion about regulatory preemption and patient access in rural areas.
A Virginia House subcommittee unanimously reported a substitute for HB 1989 that clarifies product labeling rules for medical cannabis and updates statutory language on delivery to qualified patients.
Why it matters: Sponsors and medical providers said the substitute removes ambiguity that has made dosage and labeling harder for patients to understand, and it preserves patient access — especially in rural areas — by clarifying when and how medical cannabis may be delivered. The Cannabis Control Authority told the panel it is in the process of drafting delivery regulations and asked that statutory language not unduly preempt its regulatory work.
What the substitute does
- Labeling: The substitute directs edible and topical medical cannabis products to be labeled using milligrams, while inhalable products must include percentages of THC and/or CBD. Proponents said this change will make serving sizes and dosages easier for patients and clinicians to interpret. - Delivery and verification: The substitute clarifies where and how…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
